Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma

Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.

NCT06383780 ·Status: RECRUITING ·Phase: PHASE3

Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma

NCT04554524 ·Status: UNKNOWN ·Phase: PHASE4

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

NCT04220528 ·Status: UNKNOWN ·Phase: PHASE2

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

NCT06197776 ·Status: RECRUITING

Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients

NCT06790797 ·Status: RECRUITING

Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates

NCT00765687 ·Status: COMPLETED ·Phase: PHASE4

Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells)

NCT03772496 ·Status: UNKNOWN ·Phase: NA

Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma

NCT06676293 ·Status: COMPLETED ·Phase: NA

Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer

NCT02724176 ·Status: COMPLETED ·Phase: NA

Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma

NCT06520319 ·Status: RECRUITING ·Phase: PHASE1

Intra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC

NCT06725498 ·Status: RECRUITING ·Phase: PHASE2

SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of Immunotherapy

NCT06676722 ·Status: RECRUITING ·Phase: PHASE2

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

NCT04952597 ·Status: COMPLETED ·Phase: PHASE2

Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis

NCT04171986 ·Status: UNKNOWN ·Phase: NA

Clinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATC

NCT06856278 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Molecular Analysis and Treatment Options of Thymic Malignancies

NCT05667948 ·Status: RECRUITING

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

NCT05145907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer

NCT05659186 ·Status: RECRUITING ·Phase: PHASE2

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

NCT06363123 ·Status: RECRUITING

Prospective Study for Molecular Biomarkers and Spatial Transcriptomics of Nasopharyngeal Carcinoma

NCT05912582 ·Status: NOT_YET_RECRUITING

Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer

NCT04522687 ·Status: RECRUITING

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

NCT06062563 ·Status: UNKNOWN ·Phase: NA

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

NCT06186726 ·Status: RECRUITING ·Phase: PHASE2

Application of 68Ga-Pentixafor PET/CT for Thymoma

NCT06086327 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer

NCT06746870 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2